Effects of vascular endothelial growth factor (VEGF) vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney

被引:29
作者
Klanke, B
Simon, M
Rockl, W
Weich, HA
Stolte, H
Grone, HJ [1 ]
机构
[1] Philipps Univ Marburg, Dept Pathol, Klinikum Lahnberge, D-35043 Marburg, Germany
[2] Hannover Med Sch, Dept Nephrol, D-3000 Hannover, Germany
[3] Gesell Biotechnol Forsch GmbH, Dept Gene Express, D-3300 Braunschweig, Germany
关键词
vascular endothelial growth factor; vascular permeability factor; endothelium-dependent vasodilatation; endothelium-derived relaxing factor; glomerular permeability; N-W-nitro-L-arginine;
D O I
10.1093/ndt/13.4.875
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Vascular endothelial growth factor (VEGF) or vascular permeability factor (VPF) is a selective mitogen for endothelial cells; it increases microvascular permeability and has been shown to relax isolated canine coronary arteries by an endothelium-dependent mechanism. In many tissues VEGF/VPF is expressed after an appropriate stimulus, mostly hypoxia. In the kidney VEGF/VPF is constitutively expressed in glomerular podocytes and epithelia of collecting duct. Glomerular and peritubular capillary endothelia also constitutively express specific VEGF receptors. The in vivo function of renal VEGF/VPF is unknown. Method. In the present study the effects of human recombinant VEGF(165), on renal haemodynamics and glomerular permselectivity was investigated in the isolated perfused kidney of the rat. Results. In kidneys preconstricted by noradrenaline (NA 1.5x10(-7) mol/l) VEGF/VPF (155 pmol/l) caused an almost complete return of renal perfusion flow rate to pre-NA values (before NA 113+/-4%, after NA 100%, 15 min with VEGF/VPF 111+/-4%). Shortly after VEGF/VPF administration VEGF/VPF-induced relaxation commenced, and became significant after 2 min (15 min with VEGF/VPF vs without VEGF/VPF 111+/-4% vs 103+/-2%; P < 0.05). In the presence of the NO-synthase inhibitor N-w-nitro-L-arginine (L-NNA; 5 x 10(-5) mol/l) VEGF/VPF caused only small, transient relaxations (before NNA 109+/-5%, after NNA 100%, 15 min with VEGF 95+/-2%). The cyclooxygenase inhibitor diclofenac failed to inhibit the relaxing activity of VEGF/VPF (before NA 119+/-4%, after NA+diclofenac 100%, 15 min with VEGF/VPF 123+/-5%). VEGF demonstrated no significant increase in renal protein excretion rate (after NA pretreatment (=100%): 12.5 min with VEGF/VPF vs without VEGF/VPF: 119+/-10% vs 132+/-11%, n.s.) (after NNA pretreatment (=100%) 12.5 min with VEGF/VPF vs without VEGF/VPF 94+/-5% vs 96+/-4%; n.s.) or clearance quotient of albumin. Glomerular filtration rate was not influenced by VEGF/VPF in kidneys pretreated with NA (before NA 105+/-5%, after NA 100%, 12.5 min with VEGF/VPF 94+/-2%) or with NNA (before NNA 107+/-6%, after NNA 100%, 12.5 min with VEGF/VPF 96+/-2%). Fractional glucose and fractional sodium excretion showed flow-dependent changes. Conclusion. VEGF/VPF can contribute to the relaxing capacity of the renal vasculature. This relaxation is partly mediated by the NO/endothelium-derived relaxing factor (EDRF) pathway. In the isolated perfused rat kidney the glomerular permeability for albumin is not affected by VEGF/VPF.
引用
收藏
页码:875 / 885
页数:11
相关论文
共 39 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]  
BROCK TA, 1991, AM J PATHOL, V138, P213
[3]   VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA AND PROTEIN EXPRESSION IN HUMAN KIDNEY [J].
BROWN, LF ;
BERSE, B ;
TOGNAZZI, K ;
MANSEAU, EJ ;
VANDEWATER, L ;
SENGER, DR ;
DVORAK, HF ;
ROSEN, S .
KIDNEY INTERNATIONAL, 1992, 42 (06) :1457-1461
[4]   AMINO-ACID AND CDNA SEQUENCES OF A VASCULAR ENDOTHELIAL-CELL MITOGEN THAT IS HOMOLOGOUS TO PLATELET-DERIVED GROWTH-FACTOR [J].
CONN, G ;
BAYNE, ML ;
SODERMAN, DD ;
KWOK, PW ;
SULLIVAN, KA ;
PALISI, TM ;
HOPE, DA ;
THOMAS, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) :2628-2632
[5]   VASCULAR-PERMEABILITY FACTOR - A UNIQUE REGULATOR OF BLOOD-VESSEL FUNCTION [J].
CONNOLLY, DT .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) :219-223
[6]  
CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017
[7]   GLOMERULAR PERMEABILITY .1. FERRITIN TRANSFER ACROSS NORMAL GLOMERULAR CAPILLARY WALL [J].
FARQUHAR, MG ;
PALADE, GE ;
WISSIG, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1961, 113 (01) :47-&
[8]   VASCULAR-PERMEABILITY FACTOR ENDOTHELIAL GROWTH-FACTOR (VPF/VEGF) - ACCUMULATION AND EXPRESSION IN HUMAN SYNOVIAL-FLUIDS AND RHEUMATOID SYNOVIAL TISSUE [J].
FAVA, RA ;
OLSEN, NJ ;
SPENCERGREEN, G ;
YEO, KT ;
YEO, TK ;
BERSE, B ;
JACKMAN, RW ;
SENGER, DR ;
DVORAK, HF ;
BROWN, LF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :341-346
[9]   PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS [J].
FERRARA, N ;
HENZEL, WJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :851-858
[10]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32